• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

窦状隙阻塞综合征。

Sinusoidal obstruction syndrome.

机构信息

Division of Clinical Pathology of University Hospital, Geneva, Switzerland.

出版信息

Clin Liver Dis. 2010 Nov;14(4):651-68. doi: 10.1016/j.cld.2010.07.009.

DOI:10.1016/j.cld.2010.07.009
PMID:21055688
Abstract

Sinusoidal obstruction syndrome (SOS), formerly named venoocclusive disease, is a well-known complication of hematopoietic stem cell transplantation and ingestion of food or drinks contaminated by pyrrolizidine alkaloids. Many other drugs and toxins have been associated with SOS, including several chemotherapeutic agents and immunosuppressors. SOS contributes to significant morbidity and mortality in all these settings. This review describes the histologic lesions of SOS, details its pathogenesis as it is understood today, specifies the recent data on its causes and how it may influence clinical management of colorectal liver metastases, and discusses the current knowledge on diagnosis and preventive options.

摘要

窦状隙阻塞综合征(SOS),以前称为静脉阻塞性疾病,是造血干细胞移植和摄入被吡咯里西啶生物碱污染的食物或饮料的已知并发症。许多其他药物和毒素与 SOS 有关,包括几种化疗药物和免疫抑制剂。在所有这些情况下,SOS 都会导致严重的发病率和死亡率。本综述描述了 SOS 的组织学病变,详细说明了目前对其发病机制的理解,具体说明了最近关于其病因的资料以及它如何影响结直肠肝转移的临床管理,并讨论了目前关于诊断和预防选择的知识。

相似文献

1
Sinusoidal obstruction syndrome.窦状隙阻塞综合征。
Clin Liver Dis. 2010 Nov;14(4):651-68. doi: 10.1016/j.cld.2010.07.009.
2
[Sinusoidal obstruction disease (SOS), previous hepatic venoocclusive disease (VOD)--still serious complication after hematopoietic stem cell transplantation].[窦性阻塞疾病(SOS),既往肝静脉闭塞病(VOD)——造血干细胞移植后仍严重的并发症]
Przegl Lek. 2008;65(4):203-8.
3
Hepatic veno-occlusive disease (sinusoidal obstruction syndrome) after hematopoietic stem cell transplantation.造血干细胞移植后肝静脉闭塞病(窦性阻塞综合征)
Mayo Clin Proc. 2003 May;78(5):589-98. doi: 10.4065/78.5.589.
4
Sinusoidal obstruction syndrome.窦状隙阻塞综合征。
Clin Res Hepatol Gastroenterol. 2020 Sep;44(4):480-485. doi: 10.1016/j.clinre.2020.03.019. Epub 2020 Apr 3.
5
Decreased hepatic nitric oxide production contributes to the development of rat sinusoidal obstruction syndrome.肝脏一氧化氮生成减少促成大鼠肝窦阻塞综合征的发展。
Hepatology. 2003 Oct;38(4):900-8. doi: 10.1053/jhep.2003.50383.
6
Predicting high grade lesions of sinusoidal obstruction syndrome related to oxaliplatin-based chemotherapy for colorectal liver metastases: correlation with post-hepatectomy outcome.预测结直肠肝转移瘤患者接受奥沙利铂为基础的化疗后发生肝窦阻塞综合征高分级病变:与肝切除术后结局的相关性。
Ann Surg. 2010 Mar;251(3):454-60. doi: 10.1097/SLA.0b013e3181c79403.
7
Sinusoidal obstruction syndrome.窦状隙阻塞综合征。
Clin Res Hepatol Gastroenterol. 2016 Sep;40(4):378-85. doi: 10.1016/j.clinre.2016.01.006. Epub 2016 Mar 30.
8
Review article: updates in the pathogenesis and therapy of hepatic sinusoidal obstruction syndrome.综述文章:肝窦阻塞综合征发病机制与治疗的新进展
Aliment Pharmacol Ther. 2006 Jan 1;23(1):11-25. doi: 10.1111/j.1365-2036.2006.02742.x.
9
Understanding the Similarities and Differences between Hepatic and Pulmonary Veno-Occlusive Disease.了解肝性和肺性静脉闭塞病的异同。
Am J Pathol. 2019 Jun;189(6):1159-1175. doi: 10.1016/j.ajpath.2019.02.007. Epub 2019 Mar 26.
10
Sinusoidal obstruction syndrome (SOS): A light and electron microscopy study in human liver.窦性阻塞综合征(SOS):人体肝脏的光镜和电镜研究
Micron. 2016 May;84:17-22. doi: 10.1016/j.micron.2016.02.006. Epub 2016 Feb 15.

引用本文的文献

1
Drug-induced hepatic sinusoidal obstruction syndrome: current advances and future perspectives.药物性肝窦阻塞综合征:当前进展与未来展望
Arch Toxicol. 2025 Mar;99(3):835-850. doi: 10.1007/s00204-024-03950-9. Epub 2024 Dec 24.
2
Gadoxetic acid-enhanced magnetic resonance imaging in the assessment of hepatic sinusoidal obstruction syndrome in a mouse model.钆塞酸二钠增强磁共振成像在小鼠模型肝窦阻塞综合征评估中的应用
World J Hepatol. 2024 Aug 27;16(8):1167-1176. doi: 10.4254/wjh.v16.i8.1167.
3
Impact of chemotherapeutic agents on liver microenvironment: oxaliplatin create a pro-metastatic landscape.
化疗药物对肝脏微环境的影响:奥沙利铂造成有利于转移的环境。
J Exp Clin Cancer Res. 2023 Sep 11;42(1):237. doi: 10.1186/s13046-023-02804-z.
4
Hepatic venous pressure gradient in sinusoidal obstruction syndrome: diagnostic value and link with histological lesions.窦性阻塞综合征中的肝静脉压力梯度:诊断价值及与组织学病变的关联
JHEP Rep. 2022 Aug 17;4(11):100558. doi: 10.1016/j.jhepr.2022.100558. eCollection 2022 Nov.
5
Multiparametric MRI with MR elastography findings in patients with sinusoidal obstruction syndrome after oxaliplatin-based chemotherapy.基于奥沙利铂化疗后出现窦性阻塞综合征患者的多参数磁共振成像及磁共振弹性成像结果
Insights Imaging. 2022 Sep 5;13(1):147. doi: 10.1186/s13244-022-01281-w.
6
Monocrotaline Toxicity Alters the Function of Hepatocyte Membrane Transporters in Rats.野百合碱中毒改变大鼠肝细胞膜转运蛋白的功能。
Int J Mol Sci. 2022 Jul 19;23(14):7928. doi: 10.3390/ijms23147928.
7
Pyrrolizidine alkaloids cause cell cycle and DNA damage repair defects as analyzed by transcriptomics in cytochrome P450 3A4-overexpressing HepG2 clone 9 cells.细胞色素 P450 3A4 过表达 HepG2 克隆 9 细胞中转录组分析显示吡咯里西啶生物碱导致细胞周期和 DNA 损伤修复缺陷。
Cell Biol Toxicol. 2022 Apr;38(2):325-345. doi: 10.1007/s10565-021-09599-9. Epub 2021 Apr 21.
8
Morphometric changes and imaging findings of diffuse liver disease in relation to intrahepatic hemodynamics.弥漫性肝病的形态学改变及影像学表现与肝内血流动力学的关系。
Jpn J Radiol. 2020 Sep;38(9):833-852. doi: 10.1007/s11604-020-00978-6. Epub 2020 Apr 28.
9
Splenomegaly in Colon Cancer During Adjuvant Oxaliplatin-based Chemotherapy.辅助奥沙利铂化疗期间结肠癌患者的脾肿大
Cureus. 2020 Mar 10;12(3):e7230. doi: 10.7759/cureus.7230.
10
Heterogeneity of Liver Disease in Common Variable Immunodeficiency Disorders.常见可变免疫缺陷疾病中的肝脏疾病异质性。
Front Immunol. 2020 Feb 28;11:338. doi: 10.3389/fimmu.2020.00338. eCollection 2020.